Cryoablation of the prostate: Technical recommendations

Prostate Cancer and Prostatic Diseases

Volumn 12, Issue 4, 2009, Pages 339-346

  Cytron, S ^a   Greene, D ^b   Witzsch, U ^c   Nylund, P ^d   Bjerklund Johansen, T E ^e  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^c KRANKENHAUS NORDWEST   (Germany)

^d VAASA CENTRAL HOSPITAL   (Finland)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE SCINTISCANNING; BRACHYTHERAPY; CANCER STAGING; CELL DEATH; CRYOABLATION; CRYOTHERAPY; ECHOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FREEZE THAWING; HUMAN; NEEDLE; PATIENT POSITIONING; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM TEMPERATURE; SALVAGE THERAPY;

CRYOSURGERY; HUMANS; MALE; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SALVAGE THERAPY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 70649095320     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2009.26     Document Type: Article

References (26)

1. Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H et al. EAU guidelines on prostate cancer. Eur Urol 2005; 48: 546.
2. American Urological Association. Best policy statement on the treatment of cryosurgery for the treatment of localized prostate cancer. AUA Annual Meeting, Maryland, 17-22 May 2008.
3. National Institute of Clinical Excellence. Cryotherapy as a primary treatment for prostate cancer. 2005.
4. National Institute of Clinical Excellence. Cryotherapy for recurrent prostate cancer. 2005. www.nice.org.uk.
5. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int 2005; 95: 1187.
6. Clarke DM, Baust JM, Van Buskirk RG, Baust JG. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Cryobiology 2004; 49 45.
7. Tatsutani K, Rubinsky B, Onik G, Dahiya R. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology 1996; 48: 441.
8. Soanes WA, Gonder MJ. Use of cryosurgery in prostatic cancer. J Urol 1968; 99: 793.
9. EAU guidelines on prostate cancer. http://www.uroweb.org/files/ uploaded_files/guidelines/07%20Prostate%20Cancer.pdf
10. Lane BR, Stein DE, Remzi FH, Strong SA, Fazio VW, Angermeier KW. Management of radiotherapy induced rectourethral fistula. J Urol 2006; 175: 1382.
11. Moreira Jr SG, Seigne JD, Ordorica RC, Marcet J, Pow-Sang JM, Lockhart JL. Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma. BJU Int 2004; 93: 31.
12. Cytron S, Paz A, Kravchick S, Shumalinski D, Moore J. Active rectal wall protection using direct transperineal cryo-needles for histologically proven prostate adenocarcinomas. Eur Urol 2003; 44: 315.
13. Izawa JI, Perrotte P, Greene GF, Scott S, Levy L, McGuire E et al. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol 2001; 165: 86.
14. Chin JL, Touma N, Pautler SE, Guram KS, Bella AJ, Downey DB et al. Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. J Urol 2003; 170 (4 Pt 1): 1199.
15. Touma NJ, Izawa JI, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 2005; 173: 373.
16. Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT. Salvage radical prostatectomy: Outcome measured by serum prostate specific antigen levels. J Urol 1995; 153: 104.
17. Amling CL, Lerner SE, Martin SK, Slezak JM, Blute ML, Zincke H. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 1999; 161: 857.
18. Ahlering TE, Lieskovsky G, Skinner DG. Salvage surgery plus androgen deprivation for radioresistant prostatic adenocarcinoma. J Urol 1992; 147 (3 Pt 2): 900.
19. Garzotto M, Wajsman Z. Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: Results at 5-year followup. J Urol 1998; 159: 950.
20. Izawa JI, Madsen LT, Scott SM, Tran JP, McGuire EJ, Von Eschenbach AC et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: Variables affecting patient outcome. J Clin Oncol 2002; 20: 2664.
21. Katz AE, Ghafar MA. Selection of salvage cryotherapy patients. Rev Urol 2002; 4 (Suppl 2): S18.
22. De La Taille A, Benson MC, Bagiella E, Burchardt M, Shabsigh A, Olsson CA et al. Cryoablation for clinically localized prostate cancer using an argon-based system: Complication rates and biochemical recurrence. BJU Int 2000; 85: 281.
23. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60 (2 Suppl 1): 3.
24. Consensus statement. Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37: 1035.
25. Shelley M, Wilt TJ, Coles B, Mason MD. Cryotherpay for localised prostate cancer. Cochrane database Syst Rev 2007, July 18(3): CD005010.
26. Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE. Whole gland primary prostate cryoablation: Initial results from the cryo on-line data registry. J Urol 2008; 180: 554.